Marlene Fonseca

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

African American

Top Venues

Clinical and translational science

Journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Marlene Fonseca, Andreia Guimarães, Helena Gama, Luís Magalhães, Sara Carolina Henriques, Nuno Silva, Luis Almeida, Patrício Soares-da-Silva
Drug-Drug Interaction between Oral Zamicastat and Continuous Epoprostenol Infusion at Steady-State Conditions in Healthy Subjects. Journal of clinical pharmacology (2024)
Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)
Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)
Marlene Fonseca, Cheila Ribeiro, Guillermo Castilla-Fernández, Helena Gama, Luís Magalhães, Sara Carolina Henriques, Nuno Silva, Filipe Pinto, Luís Almeida, Patricio Soares-Da-Silva
Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double-blind, randomized, placebo-controlled study in healthy subjects. British journal of clinical pharmacology (2024)
Christine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, Marlene Fonseca, Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239. Clinical and translational science 17 (7) (2024)